Issued Patents All Time
Showing 26–50 of 111 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8039217 | Proteomic interaction and genomic action determinations in the presence of associated redox state conditions | — | 2011-10-18 |
| 7968533 | Ethyl nitrite as a gastrointestinal smooth muscle relaxant and diagnostic and therapeutic uses thereof | Kevin P. Hurley, John H. Baillie, James D. Reynolds, Stephen Vaughan | 2011-06-28 |
| 7956062 | Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof | Eric J. Toone, Joshua M. Hare | 2011-06-07 |
| 7795219 | Use of an agent that restores tissue perfusion and oxygenation | Mark W. Dewhirst, Timothy J. McMahon, Pierre Sonveaux | 2010-09-14 |
| 7790204 | Use of an agent that restores tissue perfusion and oxygenation | Mark W. Dewhirst, Timothy J. McMahon, Pierre Sonveaux | 2010-09-07 |
| 7785616 | C-nitroso compounds and use thereof | Eric J. Toone | 2010-08-31 |
| 7776925 | Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria | Zhiqiang Chen, Thomas Munzel | 2010-08-17 |
| 7745656 | Stable no-delivering compounds | Eric J. Toone | 2010-06-29 |
| 7691907 | Methods and composition based on discovery of metabolism of nitroglycerin | Zhiqiang Chen | 2010-04-06 |
| 7625907 | Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof | Eric J. Toone, Joshua M. Hare | 2009-12-01 |
| 7615535 | Inhibiting GS-FDH to modulate no bioactivity | Limin Liu, Alfred Hausladen, Raphael Nudelman | 2009-11-10 |
| 7538193 | NO-modified hemoglobins and uses therefor | — | 2009-05-26 |
| 7531164 | Preventing bacterial or viral infectivity and composition containing infection preventing additive | Yehia Daaka | 2009-05-12 |
| 7417109 | Polymers for delivering nitric oxide in vivo | Eric J. Toone, Richard S. Stack | 2008-08-26 |
| 7358043 | Proteomic interaction and genomic action determinations in the presence of associated redox state conditions | — | 2008-04-15 |
| 7338670 | Use of an agent that restores tissue perfusion and oxygenation | Mark W. Dewhirst, Timothy J. McMahon, Pierre Sonveaux | 2008-03-04 |
| 7329543 | Red blood cells loaded with S-nitrosothiol and uses therefor | Joseph Bonaventura, John Pawloski, Timothy J. McMahon | 2008-02-12 |
| 7259250 | C-nitroso compounds and use thereof | Eric J. Toone | 2007-08-21 |
| 7229762 | Proteomic screening for redox state dependent protein—protein interactions | Akio Matsumoto | 2007-06-12 |
| 7202340 | No-modified hemoglobins and uses therefor | Andrew J. Gow | 2007-04-10 |
| 7179791 | Inhibiting GS-FDH to modulate NO bioactivity | Limin Liu, Alfred Hausladen, Raphael Nudelman | 2007-02-20 |
| 7157500 | Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality | Joseph Loscalzo, Daniel Simon, David Singel | 2007-01-02 |
| 7112563 | Therapies using hemoproteins | Alfred Hausladen | 2006-09-26 |
| 7087709 | Polymers for delivering nitric oxide in vivo | Eric J. Toone, Richard S. Stack | 2006-08-08 |
| 7067659 | Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof | Eric J. Toone, Joshua M. Hare | 2006-06-27 |